Loss of the Coronary Artery Disease Risk Gene Leiomodin1 in Vascular Smooth Muscle Cells Triggers Rapid Onset Coronary Atherosclerosis

This study demonstrates that vascular smooth muscle cell-specific loss of the coronary artery disease risk gene Leiomodin1 triggers rapid, diffuse coronary atherosclerosis in mice through a thrombospondin-dependent mechanism that is independent of the protein's actin nucleation function.

The Gist

The Big Picture: A "Leaky" Heart Valve

Imagine your coronary arteries (the tiny pipes that feed your heart muscle) are like a high-pressure garden hose. Inside these pipes, there is a layer of "construction workers" called Vascular Smooth Muscle Cells (VSMCs). Their job is to keep the pipe walls strong, flexible, and organized.

This study discovered that one specific protein, Leiomodin1 (LMOD1), acts like the foreman for these construction workers. When the foreman is present, the workers stay put and do their job. But when the foreman is missing, the workers go haywire, causing the pipes to clog up with gunk (plaque) incredibly fast.

The Problem: The "Lethal" Mouse Dilemma

Scientists knew that LMOD1 is a risk factor for heart disease in humans. They wanted to study what happens when this protein is missing in mice.

• The Catch: If you delete the gene for LMOD1 in a mouse's whole body, the mouse dies as a baby because its stomach and bladder muscles stop working. It's like removing the engine from a car and the brakes at the same time—the car can't move, and it crashes immediately.
• The Solution: The researchers used a special "genetic switch" (called Itga8-CreERT2) that acts like a laser-guided scalpel. They could turn off the LMOD1 gene only in the heart's blood vessels, leaving the stomach and bladder alone. This allowed them to create adult mice that were healthy everywhere except their coronary arteries.

The Discovery: The "Tofu" Heart

When they put these special mice on a "bad diet" (high fat and cholesterol), something shocking happened:

1. Speed: While normal mice take months or years to develop heart disease, these mice developed severe blockages in their heart arteries in just six days.
2. Specificity: The clogging happened only in the heart arteries. The arteries in the brain, kidneys, and legs remained perfectly clean. It was as if the heart arteries had a unique "weakness" that was triggered by the missing foreman.
3. The Look: When they looked at the hearts, the clogged arteries looked soft and white, like tofu. This is a sign of massive lipid (fat) buildup.

The Mechanism: The Great Escape and the Greedy Cells

How did the clogging happen? The researchers used a high-tech "tracking system" (lineage tracing) to watch the cells.

• The Migration: Normally, the construction workers (VSMCs) stay in the middle layer of the pipe wall. Without the LMOD1 foreman, they panicked and started migrating through the pipe wall into the inner layer (the intima) where the blood flows.
• The Foam Cells: Once inside, these workers didn't just sit there; they started eating the fat in the blood. They became "foam cells" (cells filled with fat bubbles).
• The Stat: In the clogged areas, 46% of the cells were actually these runaway construction workers, not the usual immune cells (macrophages) that usually cause heart attacks.

The Culprit: Thrombospondin-1 (Thbs1)

The researchers asked: Why are these cells eating so much fat?
They found that when LMOD1 is missing, the cells start producing a protein called Thrombospondin-1 (Thbs1).

• The Analogy: Think of Thbs1 as a greedy magnet. When it appears on the surface of the VSMCs, it grabs onto the fat particles in the blood and pulls them inside the cell.
• The Fix: When the scientists used a "genetic eraser" (shRNA) to stop the production of Thbs1, the cells stopped eating the fat, and the heart disease didn't happen. This suggests that blocking Thbs1 could be a new way to treat heart disease.

The Twist: It's Not About "Muscle Building"

For a long time, scientists thought LMOD1's only job was to help build actin, a structural protein that acts like the steel rebar inside concrete. They thought that if you removed the foreman, the "rebar" would collapse, causing the wall to crumble.

• The Surprise: The researchers created a mutant version of LMOD1 that could not build rebar (actin) but was still present in the cell.
• The Result: Even though the "rebar" wasn't being built, the mice did not get heart disease.
• The Conclusion: The heart disease wasn't caused by the loss of structural strength. It was caused by a different, unknown function of LMOD1 that keeps the "greedy magnet" (Thbs1) turned off.

Why This Matters

1. A New Model: This is the first time scientists have a mouse model that gets heart disease specifically in the coronary arteries so quickly. This is a huge win for testing new drugs.
2. New Target: They found that Thrombospondin-1 is the key to the fat uptake. If we can develop drugs to block Thbs1, we might be able to stop VSMCs from turning into fat-filled foam cells, potentially preventing heart attacks.
3. Genetic Insight: It explains why certain genetic variations in humans (SNVs) that lower LMOD1 levels slightly might increase heart disease risk, even if the person doesn't have a total genetic defect.

In short: When the "foreman" (LMOD1) is missing from the heart's blood vessel walls, the construction workers (VSMCs) panic, run into the blood flow, and start greedily eating fat because a "magnet" (Thbs1) turns on. This clogs the heart pipes in record time. Stopping the magnet stops the clogging.

Technical Summary

1. Problem Statement

• Clinical Context: Coronary artery disease (CAD) is the leading cause of death globally, driven by atherosclerosis. While Genome-Wide Association Studies (GWAS) have identified hundreds of risk alleles, the mechanisms of most remain unknown.
• Specific Gap: Leiomodin1 (LMOD1) is a vascular smooth muscle cell (VSMC)-restricted CAD risk gene. However, its role in coronary pathophysiology has been unexplored because global knockout of Lmod1 in mice is lethal due to severe visceral myopathy (intestinal and bladder dysfunction) in neonates.
• Challenge: Traditional VSMC-specific Cre drivers (e.g., Myh11-CreERT2) also target visceral smooth muscle, leading to the same lethal phenotype, thereby preventing the study of chronic vascular phenotypes in adult mice.

2. Methodology

The authors employed a multi-modal approach combining advanced genetics, high-resolution imaging, and multi-omics to bypass the lethality barrier and characterize the disease mechanism.

• Genetic Models:
  • Conditional Knockout: Generated Lmod1 floxed mice crossed with Itga8-CreERT2. The Itga8 driver is restricted to vascular smooth muscle cells (VSMCs), sparing visceral smooth muscle, thus avoiding lethal intestinal myopathy.
  • Controls: Compared against Myh11-CreERT2 (which caused lethal intestinal distention) and wild-type (WT) controls.
  • Haploinsufficiency Model: Created an 11.35 kb intronic deletion in mice to mimic the human CAD-associated SNV (rs34091558), resulting in ~50% reduction of LMOD1.
  • Nucleation-Deficient Model: Generated a knock-in mouse (Lmod1iND) expressing a mutant LMOD1 protein with five amino acid substitutions in the leucine-rich repeat (LRR) domain, rendering it defective in actin nucleation but still expressed.
• Atherogenic Regimens:
  • Mice were subjected to PCSK9 (AAV8-D377Y) + High-Fat Diet (HFD) or Apoe-/- + Western Diet (WD).
  • Some cohorts received Angiotensin II to test for aneurysm formation.
• Imaging and Lineage Tracing:
  • Immunogold Electron Microscopy Lineage Tracing (IEMLT): A novel assay using mTmG reporters and anti-GFP immunogold labeling to distinguish VSMC-derived cells from other cell types in plaques at the ultrastructural level.
  • Confocal Immunofluorescence (CIFM) & TEM: Used to visualize lipid accumulation, fibrous caps, and cell migration.
• Omics and Molecular Analysis:
  • Spatial Transcriptomics (Visium) & scRNA-seq: Performed on heart sections to map cell composition and gene expression specifically within coronary arteries.
  • Spatial Mass Spectrometry Imaging (SMI): To profile lipid species within atheromata.
  • In Vitro Rescue: Lentiviral transduction of VSMCs with WT Lmod1, nucleation-deficient Lmod1ND, or Thbs1 shRNA to test mechanistic rescue.

3. Key Contributions

1. Development of a Viable CAD Model: Successfully overcame the neonatal lethality of Lmod1 loss by utilizing the Itga8-CreERT2 driver, establishing the first mouse model where VSMC-specific loss of a CAD risk gene triggers rapid, occlusive coronary atherosclerosis.
2. Discovery of Rapid Onset Phenotype: Demonstrated that Lmod1 loss leads to diffuse, occlusive coronary atherosclerosis within 6–8 days of an atherogenic challenge, a timeline unprecedented in standard mouse models.
3. Lineage Tracing Breakthrough: Provided the first quantitative evidence in adult mouse coronary arteries that ~46% of plaque cells are of VSMC origin, with many acting as foam cells.
4. Mechanistic Decoupling: Revealed that the atherogenic phenotype is independent of LMOD1's actin nucleation function but dependent on Thrombospondin-1 (THBS1) upregulation.

4. Key Results

• Phenotype Specificity:
  • Lmod1SMKO mice (Itga8-CreERT2) developed severe, occlusive coronary atherosclerosis with "tofu-like" gross appearance and fibrous caps.
  • Lesions were coronary-specific; other vascular beds (aorta, brain, kidney) showed little to no disease, and no aneurysms formed even with Angiotensin II.
  • Myh11-CreERT2 mice died within a week due to intestinal obstruction/sepsis, confirming the necessity of the Itga8 driver.
• Temporal Dynamics:
  • Lipid insudation and VSMC migration through the internal elastic lamina (IEL) were detected as early as 6 days post-regimen.
  • By day 63, lesions were nearly occlusive with prominent fibrous caps.
  • No myocardial infarction was observed, suggesting death was likely due to ischemic cardiomyopathy or arrhythmia from microvascular occlusion.
• Lineage Tracing (IEMLT):
  • Quantitative analysis revealed 46% of plaque cells were GFP+ (VSMC-derived).
  • 75% of VSMC-derived cells in the plaque core were foam cells; 50% of those in the fibrous cap contained lipid droplets.
  • Surprisingly, no proliferation (EdU+) or apoptosis (TUNEL+) was detected in VSMC-derived plaque cells, suggesting the phenotype is driven by migration and lipid uptake rather than clonal expansion.
• Transcriptomics & Metabolomics:
  • THBS1 Upregulation: Spatial and single-cell RNA sequencing identified a consistent, significant upregulation of Thbs1 (Thrombospondin-1) in VSMCs of Lmod1SMKO mice.
  • Lipid Pathways: SMI revealed increased sulfated cholesterol, ceramides, and sphingomyelin in lesions.
  • Inverse Correlation: LMOD1 and THBS1 expression were inversely correlated in both mouse and human coronary tissues.
• Mechanistic Rescue:
  • Actin Nucleation: Expression of a nucleation-deficient LMOD1 (Lmod1ND) in Lmod1SMKO mice fully rescued the phenotype (no lipid accumulation), despite the protein having low expression levels and no actin nucleation activity.
  • THBS1 Dependence: Knockdown of Thbs1 via shRNA in Lmod1SMKO VSMCs abolished the increased lipid uptake (oxLDL staining).
  • Haploinsufficiency: Mice with ~50% reduction in LMOD1 (mimicking the human SNV) did not develop CAD, indicating that complete loss, not just reduced levels, is required for the phenotype.

5. Significance

• Novel Pathophysiology: This study identifies a new mechanism for CAD where the loss of a cytoskeletal regulator (LMOD1) in VSMCs triggers a rapid, non-proliferative migration and lipid uptake phenotype mediated by THBS1.
• Therapeutic Target: The findings suggest that THBS1 is a viable therapeutic target to mitigate VSMC foam cell formation and atherosclerosis progression.
• Model Utility: The Lmod1SMKO mouse model offers a unique, rapid-onset system for testing novel therapeutics for coronary atherosclerosis, bypassing the long latency periods of traditional models.
• Genetic Insight: It clarifies that the CAD risk associated with LMOD1 SNVs likely requires a threshold of protein loss (haploinsufficiency is insufficient) and that the disease mechanism is distinct from the protein's canonical actin nucleation role.

In conclusion, the paper establishes that VSMC-specific loss of LMOD1 drives rapid coronary atherosclerosis through a THBS1-dependent, actin-nucleation-independent mechanism, providing a new paradigm for understanding smooth muscle cell contributions to CAD.